Cited by 405Ovarian function and disordersReproductive Biology and FertilitySexual Differentiation and Disorders

The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.

The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome

Nelson, Velen L., Qin, Ke-nan, Rosenfield, Robert L., Wood, Jennifer R., Penning, Trevor M., Legro, Richard S., Strauss, Jerome F., McAllister, Jan M.·2001·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jcem.86.12.8088

Open this paper in CoChat — free account

Abstract

Ovarian theca cells propagated from patients with polycystic ovary syndrome (PCOS) convert steroid precursors into T more efficiently than normal theca cells. To identify the basis for increased T production by PCOS theca cells, we examined type I-V 17 beta-hydroxysteroid dehydrogenase (17 beta HSD) isoform expression in long-term cultures of theca and granulosa cells isolated from normal and PCOS ovaries. RT-PCR analysis demonstrated that theca cells express type V 17 beta HSD a member of the aldo-keto reductase (AKR) superfamily (17 beta HSDV, AKR1C3), whereas expression of type I, II, and IV 17 beta HSD, which are members of the short-chain dehydrogenase/reductase superfamily, was limited to granulosa cells. Type III 17 beta HSD, the testicular isoform, was not detected in either granulosa or theca cells. Northern and real-time PCR analyses demonstrated that 17 beta HSDV transcripts were not significantly increased in PCOS theca cells compared with normal theca cells. RT-PCR analysis revealed that theca cells also express another AKR, 20 alpha HSD (AKR1C1). Both basal and forskolin-stimulated 20 alpha HSD mRNA levels were increased in PCOS theca cells compared with normal theca cells. However, 17 beta HSD enzyme activity per theca cell was not significantly increased in PCOS, suggesting that neither AKR1C3 nor AKR1C1 contributes to the formation of T in this condition. In contrast, 17 alpha-hydroxylase/C17,20 lyase and 3 beta HSD enzyme activities were elevated in PCOS theca cells, driving increased production of T precursors. These findings indicate that 1) increased T production in PCOS theca cells does not result from dysregulation of "androgenic" 17 beta HSD activity or altered expression of AKRs that may express 17 beta HSD activity; and 2) increased synthesis of T precursors is the primary factor driving enhanced T secretion in PCOS.

Integrity signals

Registry

Crossref · 10.1210/jcem.86.12.8088

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Self-citation
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649
Self-citation
Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3
Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., & Andersson, S. (1994) · Nature Genetics · doi:10.1038/ng0594-34 · Cited by 570
The Ovarian Androgen Producing Cells: A Review of Structure/Function Relationships1,2
Erickson, G. F., Magoffin, D. A., Dyer, C. A., & Hofeditz, C. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-3-371 · Cited by 569
Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries
Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Self-citation
Polycystic Ovary Syndrome as a Form of FunctionalOvarian Hyperandrogenism Due to Dysregulation ofAndrogen Secretion*
EHRMAN, D. A., Barnes, R. B., & Rosenfield, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 498
Self-citation
Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
Ehrmann, D. A. (1995) · Endocrine Reviews · doi:10.1210/er.16.3.322 · Cited by 394
The Polycystic Ovary. I. Clinical and Histologic Features
Goldzieher, J. W., & Green, J. (1962) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-22-3-325 · Cited by 369

Flagged first, then by citations

Show all 42 references

2 of the 42 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam G, eds. Current issues in endocrinology and metabolism. Polycystic ovary syndrome. Boston: Blackwell;, 377
McAllister, 1993, Human theca interna cells in culture, In: Heindel J, Chapin R, eds. Methods in toxicology. San Diego: Academic Press;, 330

Sorted by citations

Items 301–400 of 405

SERUM NESFATIN-1 LEVELS IN EXPERIMENTALLY-INDUCED POLYCYSTIC OVARY IN LEAN AND OBESE ALBINO RATS
Gerges, N., & Khalefa, A. A. (2016) · Al-Azhar Medical Journal · doi:10.12816/0034751 · Cited by 2
Exploring gut microbiome alterations and hormonal imbalances in polycystic ovary syndrome: insights from a comparative study
Patel, J., Chaudhary, H., Parekh, B., & Joshi, R. G. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02081-2 · Cited by 2
Steroidogenic enzyme dysregulation in polycystic ovary syndrome: Mechanistic insights and emerging therapeutic strategies
Thirumurugan, A., Ravi, S., & Annamalai, A. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.107088 · Cited by 1
Efficacy of ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome – Pilot study
Katica, V., Rama, A., & Abadzić, N. (2014) · Folia medica Facultatis medicinae Universitatis Saraeviensis · Cited by 1
Syndrome des ovaires polymicrokystiques
Neraud, B., Jonard-Catteau, S., & Dewailly, D. (2006) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(06)41282-5 · Cited by 1
PEDIATRIC REVIEW Polycystic ovary syndrome in adolescents
Franks, S. (2008) · Cited by 1
Zaburzenia gospodarki węglowodanowej u kobiet z zespołem wielotorbielowatych jajników (PCOS)
Kuligowska-Jakubowska, M. (2012) · Cited by 1
Le syndrome des ovaires polykystiques
Robin, G., Peigné, M., Plouvier, P., Rolland, A.-L., Catteau-Jonard, S., & Dewailly, D. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75965-9.00013-1 · Cited by 1
Síndrome de ovarios poliquísticos
Robin, G., Peigné, M., Dumont, A., Plouvier, P., Rolland, A.-L., Catteau-Jonard, S., & Dewailly, D. (2020) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(20)44039-1 · Cited by 1
Role of Statins and Resveratrol in PCOS Management
Sokalska, A., Ortega, I., & Dulęba, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_13 · Cited by 1
Sindrome dell’ovaio polimicrocistico
Neraud, B., Jonard-Catteau, S., & Dewailly, D. (2007) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(07)70395-9 · Cited by 1
Disruptors of Androgen Action and Synthesis
Sanderson, J. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801139-3.00004-1 · Cited by 1
Genetic Considerations in the Evaluation of Menstrual Cycle Irregularities
Abusag, M., Ehrmann, D. A., & Hoffman, L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00018-x · Cited by 1
Polycystic ovary syndrome: ovarian pathophysiology and consequences after the menopause
Schmidt, J. G. H. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Genes Related to Metabolic Abnormalities or Insulin Resistance in Polycystic Ovary Syndrome
Escobar-Morreale, H. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_5 · Cited by 1
What do Ovaries have to do with Sleeping?
Sundaram, S. S., & Halbower, A. C. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.06.043 · Cited by 1
Polycystic ovary syndrome and associated metabolic features in indigenous women in the Northern Territory.
Boyle, J. A. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Chemerin and Prohibitin in the Regulation of Ovarian Follicular Development and their Potential Involvement in Polycystic Ovarian Syndrome
Wang, Q. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-2980 · Cited by 1
Androgen receptor mediated activity in the ovary : implications for Polycystic Ovary Syndrome
Hickey, T. E. (2006) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Novel insights into the pathophysiology of PCOS: the role of environmental toxins
Diamanti‐Kandarakis, E. (2013) · doi:10.2217/ebo.12.237 · Cited by 1
Skin Manifestations of Paediatric Metabolic Syndrome
Holzer, G., & Volc‐Platzer, B. (2019) · Harper's Textbook of Pediatric Dermatology · doi:10.1002/9781119142812.ch72 · Cited by 1
Avaliação do perfil de miRNAs circulantes em pacientes com síndrome dos ovários policísticos
Maffazioli, G. D. N. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-16082021-130548 · Cited by 1
[Insulin sensitizers in the treatment of polycystic ovary].
Núñez, D. A. O., Marín, I. H., & Ayala, A. R. (2005) · PubMed · Cited by 1
The Menstrual Cycle in PCOS
Gill, S., & Hall, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_2
Metformin for the Treatment of Polycystic Ovary Syndrome (PCOS)
Patel, S. S., Beshay, V. E., & Carr, B. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-392-3_2
Physiological aspects of weight loss in obesity
Patel, K. (2011) · Nottingham ePrints (University of Nottingham)
Beef cattle production: Understanding the effect of heifer development system, late gestation protein supplementation, and ovarian steroidogenic environment on productivity, reproduction, and longevity
Summers, A. F. (2012) · Lincoln (University of Nebraska)
Effects of Apples and Exercise on Clinical Parameters of Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Booth, B. K. (2010)
Efectos del resveratrol en la fisiología ovárica y su potencial aplicación en el síndrome de ovario poliquístico
Sánchez, I. O. (2014) · BURJC Digital (King Juan Carlos University)
Epilepsie und polyzystisches Ovarialsyndrom
Rösing, B., & Bauer, J. M. (2012) · RWTH Publications (RWTH Aachen)
The Genetics of Insulin Resistance: Analysis of the Peroxisome Proliferator-Activated Receptor Pathway
Boudreaux, M. Y. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Genetic Considerations in the Evaluation of Menstrual Cycle Irregularities
Hoffman, L., & Ehrmann, D. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00019-5
Genomics and Polycystic Ovary Syndrome (PCOS): The Use of Microarray Analysis to Identify New Candidate Genes
Wood, J. R., & Strauss, J. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-309-7_12
Self-citation
A 9-Year-Old Girl Presenting Central Precocious Puberty with Polycystic Ovary Syndrome.
Minamitani, K., Nakajima, H., Hoshioka, A., Tamai, K., Kurosaki, T., Matsumoto, R., Minagawa, M., & Kohno, Y. (2002) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.11.77
Síndrome de los ovarios poliquísticos
Neraud, B., Jonard-Catteau, S., & Dewailly, D. (2007) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(07)70650-5
Hirsutism
Smith, D. I., Tan, C. Y., & McKenna, T. J. (2007) · The Endocrinologist · doi:10.1097/ten.0b013e3181594271
Genética del síndrome de ovarios poliquísticos
Amato, P., & Simpson, J. L. (2006) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(06)46490-0
Efeitos do treinamento físico intenso e da restrição alimentar sobre a ação da leptina mediada pelo hormônio concentrador de melanina no eixo reprodutor de ratas.
da Silva, R. J. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2011.tde-09022012-121522
HIPERANDROGENISMO EM PEDIATRIA − MANIFESTAÇÕES CLÍNICAS E ABORDAGEM
Faria, H. D. C., & Amaro, C. (2014) · Journal of the Portuguese Society of Dermatology and Venereology · doi:10.29021/spdv.71.3.188
GENETIKA SINDROMA POLICISTIČNIH JAJNIKA
Geršak, K., & Ferk, P. (2007) · Gynaecologia et perinatologia
Hormonal regulation of microRNA expression in the ovary
Luense, L. J. (2012) · KU ScholarWorks (The University of Kansas)
A study of different clinical and biochemical parameters in polycystic ovary syndrome affecting ovulation induction outcome and fertility potential
Siebert, T. I. (2008) · SUNScholar (Stellenbosch University)
The Effect of Atorvastatin, Metformin or Their Combination in Unmarried Women with Polycystic Ovary Syndrome
Abdul-Nabi, M. A. (2013)
Age-related androgen secretion in healthy women and in women with polycystic ovary syndrome
Piltonen, T. (2004)
Unravelling the link between insulin resistance and androgen excess
O’Reilly, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Acetylcholinesterase im humanen Ovar
Blohberger, J. (2015) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.19054
Evaluation of metformin treatment in patient with polycystic ovary syndrome in Kirkuk city
Mohammed, T., AL-Mandalawi, S., Sabah, I., Azzo, E., Gassan, I., & qadir, N. (2012) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2012.0009 · Cited by 1
Génétique du syndrome des ovaires polykystiques
Amato, P., & Simpson, J. L. (2006) · EMC - Gynécologie · doi:10.1016/s0246-1064(06)45020-9
Definition, Clinical Manifestations, and Prevalence
Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2010)
Prostate Specific Antigen in Polycystic Ovary Syndrome
Hadi, S. M. A., Bayatti, A. A., & Jebri, N. N. (2010) · Iraqi postgraduate Medical Journal
Bariatric Surgery in Obesity and Reversal of Metabolic Disorders
Manco, M. (2007) · CRC Press eBooks · doi:10.1201/9781420005479.pt8
El ovario poliquístico y las enfermedades dermatológicas
López, J. S. J., Escalona, A. O., & Álvarez, Á. D. (2017) · Más dermatología · doi:10.5538/1887-5181.2017.28.4
Dietary management of Polycystic ovary syndrome.
Moran, L. (2007) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Androgens Regulate Human Female Reproductive Ageing and Meiotic Fidelity
Ford, J. H. (2017)
RESISTÊNCIA À INSULINA E RISCO CARDIOVASCULAR: ASSOCIAÇÃO COM O POLIMORFISMO NO GENE PAI-1 E PARÂMETROS BIOQUÍMICOS EM MULHERES COM A SÍNDROME DOS OVÁRIOS POLICÍSTICOS
Pós-Graduação, P. D. (2012)
ARROZES ESPECIAIS: INCENTIVO A CRIAÇÕES GASTRONÔMICAS
Kosugi, M. L. (2021) · doi:10.22533/at.ed.5162101043
PERCEPÇÃO DA AUTOIMAGEM E RISCO DE TRANSTORNOS ALIMENTARES EM ESTUDANTES DE NUTRIÇÃO
Aguiar, R. C., Torrel, R. H., Lira, S. M., Lima, C. L. S., Holanda, M. O., salmito, P. A., Brito, F. C. R., Canabrava, N. D. V., Marques, C. G., da Silva, J. Y. G., et al. (2021) · doi:10.22533/at.ed.51621010417
AUXILIO DA NUTRIÇÃO NO TRATAMENTO DA ESCLEROSE LATERAL AMIOTRÓFICA
da Silva, A. D. B. B., de Oliveira, A. A. P., Lamas, G. C., & Revorêdo, J. C. P. (2021) · doi:10.22533/at.ed.5162101044
FATOR DE CORREÇÃO DE HORTALIÇAS EM SERVIÇOS DE ALIMENTAÇÃO: INDICADOR DE BOAS PRÁTICAS E SUSTENTABILIDADE
dos Santos, S. F., de Souza, P. G., Nogueira, T. B. D. B., & Fai, A. E. C. (2021) · doi:10.22533/at.ed.5162101048
ANÁLISE DA COMPOSIÇÃO NUTRICIONAL DE CARDÁPIOS DISPONIBILIZADOS POR BLOGUEIRAS EM SITES DA INTERNET
de Carvalho, V. B., Fonseca, M. L. M., Pereira, C. D. J. L., Feitosa, S. D. S., Marinho, S. C., Ferreira, J. G. C. F., Figueredo, K. A. D. S., & de Macêdo, M. R. C. (2021) · doi:10.22533/at.ed.5162101042
INSEGURANÇA ALIMENTAR EM MULHERES GESTANTES E NÃO GESTANTES
Trajano, F. M. P., de Lima, R. L. F. C., Viana, M. A. C. B. M., Trajano, M. D. C. P., Gomes, N. I. G., do Nascimento, J. A., & Vianna, R. P. D. T. (2021) · doi:10.22533/at.ed.51621010413
533/at.ed.00000000000 ADOÇÃO DE ALIMENTOS BIOFORTIFICADOS COMO ESTRATÉGIA PARA SUPRIR AS DEFICIÊNCIAS DE MICRONUTRIENTES NA ALIMENTAÇÃO ESCOLAR
Azevedo, A. O. N., Azevedo, F. T., & Nunes, C. D. R. (2021) · doi:10.22533/at.ed.5162101041
PERFIL DO ALEITAMENTO MATERNO E MORBIDADE POR DIARREIA EM CRIANÇAS COM ATÉ SEIS MESES DE VIDA
Almeida, L. M. R., dos Santos, D. B., & Carvalho, G. Q. (2021) · doi:10.22533/at.ed.51621010419
INOVAÇÃO EM NUTRIÇÃO ESPORTIVA
Abrão, A. C. S. B., & de Rossi, P. H. S. (2021) · doi:10.22533/at.ed.51621010411
IMPACTOS DA UTILIZAÇÃO DE DIETAS DA MODA NA SAÚDE DE INDIVÍDUOS EXCESSO DE PESO E OBESOS: UMA REVISÃO DE LITERATURA
do Nascimento, B. P., Santos, H. O., Lira, S. M., Lima, C. L. S., Holanda, M. O., salmito, P. A., Brito, F. C. R., Canabrava, N. D. V., Marques, C. G., da Silva, J. Y. G., et al. (2021) · doi:10.22533/at.ed.51621010412
I FEIRA DE SAÚDE E EDUCAÇÃO “ALIMENTAÇÃO SAUDÁVEL E VIDA”: CONSTRUINDO CAMINHOS PARA O CUIDADO
Barbosa, K. D. C., Dias, A. C. D. C., Macedo, G. D. S. N., & de Almeida, A. M. (2021) · doi:10.22533/at.ed.51621010421
VIVÊNCIA DE ACADÊMICA DE NUTRIÇÃO EM BANCO DE LEITE HUMANO: RELATO DE EXPERIÊNCIA
Nunes, G. T., dos Santos, G. K. P., Correia, R. L., & Helbig, E. (2021) · doi:10.22533/at.ed.51621010414
OS MÉTODOS DE INTRODUÇÃO ALIMENTAR CONVENCIONAL E BABY-LED WEANING (BLW): UMA REVISÃO INTEGRATIVA DE LITERATURA
da Silva, A. D. B. B., de Oliveira, A. A. P., Lamas, G. C., & Revorêdo, J. C. P. (2021) · doi:10.22533/at.ed.51621010415
FERRAMENTAS DE GERENCIAMENTO PARA O CONTROLE DE CUSTOS EM UNIDADES PRODUTORAS DE REFEIÇÕES (UPRs)
Sousa, C. D. O. A., & Oliveira, G. L. R. D. (2021) · doi:10.22533/at.ed.5162101049
EFFICACY OF SUPPLEMENTATION WITH MYO-INOSITOL IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME - META-ANALYSIS
de Paula, P. P. M., Gonçalves, L. C., da Silva, P. A. N., Silva, A. M. T. C., Passos, X. S., & Silva, N. M. (2021) · doi:10.22533/at.ed.5162101047
HÁBITOS ALIMENTARES APRESENTADOS POR ESTUDANTES DE UMA ESCOLA PRIVADA DE MACEIÓ/AL
Pinto, D. M. T. B. C., de Amorim, K. B., Monteiro, P. D. M., Costa, F. P. M., Pinto, V. T. B. C., Rodrigues, L. A. D. O., & Costa, E. D. A. P. (2021) · doi:10.22533/at.ed.51621010410
PERCEPÇÃO SOBRE A DIETA HOSPITALAR, MITOS E VERDADES SOBRE A ALIMENTAÇÃO DURANTE A GESTAÇÃO: RELATO DE ATIVIDADES ACADÊMICAS DE EXTENSÃO NO HU/FURG
Nunes, G. T., dos Santos, G. K. P., Correia, R. L., & Helbig, E. (2021) · doi:10.22533/at.ed.51621010418
OS PRIMEIROS MIL DIAS DA CRIANÇA: UMA JANELA DE OPORTUNIDADES À PROMOÇÃO DA ALIMENTAÇÃO SAUDÁVEL
dos Santos, A. P., Santos, S. C. F., & Silva, L. R. B. (2021) · doi:10.22533/at.ed.51621010416
Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
Patten, R. K. (2021) · Victoria University Research Repository (Victoria University)
The Metabolic Syndrome: 2009
Reasner, C. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-963-5_7
Disruptors of Androgen Action and Synthesis
Sanderson, J. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-821985-0.00021-9
Type 2 Diabetes
Srikanthan, P., Pessin, J. E., & Bar, R. S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-378-1_5
Ovarian Diseases
McGee, E. A., & Loucks, T. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_46
Endocrinological Signs
Dennis, M., Bowen, W. T., & Cho, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7295-4075-9.00007-4
Exercise interventions in women with Polycystic Ovary Syndrome
Moreno‐Asso, A., Patten, R. K., & McIlvenna, L. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89843-0.00020-9 · Cited by 1
THE IMPORTANCE OF ANTI-MULLERIAN HORMONE IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
Arkhypkina, T. L., Lyubimovа, L. P., & Tyashelova, O. V. (2011) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2011.3.02
The Metabolic Syndrome: Identification and Management of the Patient at High Risk for Cardiovascular Disease
Reasner, C. A. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.011
An Insilico Computational Screening of Siddha Formulation Kalingathy Thailam against Cyp- 17α-Hydroxylase in PCOS
Dhivya, G., Bharathy, K., Lakshmi Kantham, T., & Meenakumari, R. (2023) · International Journal of Ayurvedic Medicine · doi:10.47552/ijam.v14i2.3642
Estimation of BMP-15 gene expression and its Association to Hormonal Profile in Iraq Patient with Polycystic Ovary Syndrome
Khadhum, Z. A., & Al-Deresawi, M. S. (2024) · Wasit Journal of Pure sciences · doi:10.31185/wjps.401
Theca Cells
Richards, J. S., & Candelaria, N. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21477-6.00060-2
Optimising a Spatial Gene Expression Protocol to Track Progenitor to Theca Cell Differentiation In Situ.
Young, M. (2024) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.26828791
Effect of Myo-Inositol in Treating Polycystic Ovary Syndrome (PCOS): A Review
Alam, S. (2024) · Journal of Obstetrics and Gynecological Surgery · doi:10.52916/jogs244039
Menstrual Disorders and Hyperandrogenism in Adolescence
DiVall, S. A., & Rosenfield, R. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_27
Self-citation
Nutraceuticals in Reproductive and Urinary Disorders: A Brief Review
Nayak, S. K., Rout, S. K., Das, A. K., Patra, A. K., & Sahu, P. K. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00344
Progestin-Only Pretreatment Enhances Follicular Synchronization and Embryo Development: A Three-Arm Retrospective Cohort Study in GnRH Antagonist IVF CyclesPreprint
Kobanawa, M. (2025) · Research Square · doi:10.21203/rs.3.rs-6998674/v1
Progestin-only pretreatment enhances follicular synchronization and embryo development: a three-arm retrospective cohort study in GnRH antagonist cycles
Kobanawa, M. (2025) · Contraception and Reproductive Medicine · doi:10.1186/s40834-025-00396-x
Dihydroartemisinin for Treatment of Polycystic Ovary Syndrome: study protocol for a multi-centre placebo-controlled Randomized Clinical TrialPreprint
Mu, L., Shen, Y., Wang, G., Liu, C., Yang, H., Li, W., Mol, B. W., Li, X., Dong, X., & Jiang, J. (2025) · medRxiv · doi:10.1101/2025.11.25.25341030
Uterine Origins and Evolution in Childhood
Tsatsoulis, A. A., & Xita, N. V. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_7
Polycystic ovary syndrome - Effect of acupuncture on insulin resistance and neuroendocrine function
Johansson, J. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Additional file 1 of Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10
Chugh, R. M., Park, H.-S., Andaloussi, A. E., Elsharoud, A., Esfandyari, S., Ulin, M., Bakir, L. V., Aboalsoud, A., Ali, M., Ashour, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14926988
Self-citation
Research on the Mechanism of β-Sitosterol in Improving Polycystic Ovary Syndrome by Regulating CYP17A1/CYP19A1 Expression
张平洋 (2026) · Pharmacy Information · doi:10.12677/pi.2026.152011
Exploring the biological functions of PCOS: identifying hub androgen-related genes through bioinformatics
He, X., Su, L., Yin, J., Lai, Y., Yang, H., Yu, Z., Zheng, X., Liu, J., & Yang, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1693216
Natural Bioactive Compounds in Polycystic Ovary Syndrome: Properties, Molecular Mechanisms, and Therapeutic Potential
Linares, R., Rosas, G., Vieyra, E., Chaparro, A., Espinoza, J. A., Ramírez, D. A., Silva, C., Rosas, P., Macías, V.-M., & Morales‐Ledesma, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114715 · Cited by 1
Dihydroartemisinin for the treatment of polycystic ovary syndrome: study protocol for a multi-centre placebo-controlled randomised clinical trial
Mu, L., Shen, Y., Wang, G., Liu, C., Yang, H., Li, W., Mol, B. W., Li, X., Dong, X., & Jiang, J. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-108980
Polycystic ovary syndrome
Bass, I. R., Nosova, E. V., & Dunaif, A. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00085-8

Authors: Nelson, V. L., Qin, K.-N., Rosenfield, R. L., Wood, J. R., Penning, T. M., Legro, R. S., Strauss, J. F., & McAllister, J. M.
Affiliations: Departments of Cellular and Molecular Physiology (V.L.N., J.M.M.), Hershey, Pennsylvania 17033
Departments of Pediatrics and Medicine, University of Chicago (K.Q., R.L.R.), Chicago, Illinois 60637
Pennsylvania State University (US)
University of Pennsylvania (US)
ORCID: Rosenfield, Robert L.
Wood, Jennifer R.
Penning, Trevor M.
Legro, Richard S.
Strauss, Jerome F.
McAllister, Jan M.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2001-12-01
Volume: 86
Issue: 12
Pages: 5925-5933
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem.86.12.8088
OpenAlex: W2062389660
Cited by: 405
References: 42
Citations by year: 2026: 12 · 2025: 10 · 2024: 8 · 2023: 8 · 2022: 16 · 2021: 33 · 2020: 13 · 2019: 17 · 2018: 16 · 2017: 14 · 2016: 13 · 2015: 15 · 2014: 23 · 2013: 20 · 2012: 24
FWCI: 9.65
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (DK-47015, R01DK047015)
National Center for Research Resources (RR-00055)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-34449, R01HD033852, HD 33852, HD-39267, HD 07305, U54HD034449, R01HD039267, HD-0118)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords: polycystic ovary syndrome, theca cells, testosterone production, 17β-hydroxysteroid dehydrogenase, AKR1C3, AKR1C1, 3β-hydroxysteroid dehydrogenase, steroidogenesis, androgen production, granulosa cells, enzyme activity
MeSH terms: Adult, Cells, Cultured, Female, Granulosa Cells, Humans, Hydroxysteroid Dehydrogenases, Isoenzymes, Ovary, Polycystic Ovary Syndrome, Reference Values, RNA, Messenger, Testosterone, Theca Cells, 20-Hydroxysteroid Dehydrogenases, 3-Hydroxysteroid Dehydrogenases, Reverse Transcriptase Polymerase Chain Reaction, 20-alpha-Hydroxysteroid Dehydrogenase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks